—Mkt Cap: —P/E: —
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and inte…
Industry Peers
Health Care Technologyloading…
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value148.17M USD
Revenue (TTM)59.07M USD
Gross Profit48.34M USD
Net Income (TTM)-53.31M USD
Revenue/Share2.254 USD
Last Price—
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees223
CountryUS
SectorHealth Care
IndustryHealth Care Technology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.20
PEG—
EV/EBITDA-3.01
EV/Revenue2.51
P/S2.73
P/B5.51
EPS (TTM)-2.01
EPS (Forward)-1.89
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin85.33%
Oper. Margin-82.34%
EBITDA Margin-83.31%
Profit Margin-94.10%
ROE-135.56%
ROA-50.87%
Growth
Revenue Growth19.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-40.17M USD
CapEx (TTM)580.00K USD
FCF Margin-39.02%
FCF Yield—
Net Debt-12.91M USD
Net Debt/EBITDA0.26
Balance Sheet
Debt/Equity1.28
Current Ratio10.20
Quick Ratio8.58
Book Value/Sh1.101 USD
Cash/Share2.725 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)11.17 USD
Target Range6.000 USD – 14.00 USD
# Analysts6
Ownership
Shares Out.26.54M
Float18.39M
Insiders9.33%
Institutions63.56%
Short Interest
Short Ratio6.5d
Short % Float9.28%
Short % Out.6.61%
Shares Short1.75M
Short (prev mo.)1.69M
Technical
SMA 507.619 USD
SMA 2007.920 USD
Beta0.87
S&P 52W Chg28.31%
Avg Vol (30d)—
Avg Vol (10d)551.75K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—